Myles Minter
Stock Analyst at William Blair
(0.76)
# 3,827
Out of 4,876 analysts
21
Total ratings
43.75%
Success rate
-14.14%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Myles Minter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VERV Verve Therapeutics | Downgrades: Market Perform | n/a | $11.31 | - | 1 | Jun 17, 2025 | |
| VIGL Vigil Neuroscience | Downgrades: Market Perform | n/a | $7.95 | - | 1 | May 22, 2025 | |
| IMUX Immunic | Initiates: Outperform | n/a | $0.69 | - | 1 | Mar 25, 2025 | |
| CAMP Camp4 Therapeutics | Initiates: Outperform | n/a | $1.55 | - | 1 | Nov 5, 2024 | |
| ARGX argenx SE | Upgrades: Outperform | n/a | $559.75 | - | 2 | Nov 1, 2024 | |
| KRRO Korro Bio | Initiates: Outperform | n/a | $12.03 | - | 1 | Aug 14, 2024 | |
| NMRA Neumora Therapeutics | Initiates: Outperform | n/a | $0.77 | - | 1 | Oct 10, 2023 | |
| ARCT Arcturus Therapeutics Holdings | Initiates: Outperform | $71 | $13.44 | +428.27% | 1 | Jul 24, 2023 | |
| MRNA Moderna | Initiates: Market Perform | n/a | $27.15 | - | 1 | Jul 24, 2023 | |
| VRTX Vertex Pharmaceuticals | Initiates: Outperform | n/a | $440.98 | - | 1 | May 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $42.91 | - | 2 | Mar 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $3.02 | - | 3 | Sep 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $322.59 | - | 1 | Jun 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $39.84 | - | 2 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $1.47 | - | 1 | Sep 27, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $116 | $125.44 | -7.53% | 1 | Feb 24, 2020 |
Verve Therapeutics
Jun 17, 2025
Downgrades: Market Perform
Price Target: n/a
Current: $11.31
Upside: -
Vigil Neuroscience
May 22, 2025
Downgrades: Market Perform
Price Target: n/a
Current: $7.95
Upside: -
Immunic
Mar 25, 2025
Initiates: Outperform
Price Target: n/a
Current: $0.69
Upside: -
Camp4 Therapeutics
Nov 5, 2024
Initiates: Outperform
Price Target: n/a
Current: $1.55
Upside: -
argenx SE
Nov 1, 2024
Upgrades: Outperform
Price Target: n/a
Current: $559.75
Upside: -
Korro Bio
Aug 14, 2024
Initiates: Outperform
Price Target: n/a
Current: $12.03
Upside: -
Neumora Therapeutics
Oct 10, 2023
Initiates: Outperform
Price Target: n/a
Current: $0.77
Upside: -
Arcturus Therapeutics Holdings
Jul 24, 2023
Initiates: Outperform
Price Target: $71
Current: $13.44
Upside: +428.27%
Moderna
Jul 24, 2023
Initiates: Market Perform
Price Target: n/a
Current: $27.15
Upside: -
Vertex Pharmaceuticals
May 30, 2023
Initiates: Outperform
Price Target: n/a
Current: $440.98
Upside: -
Mar 6, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $42.91
Upside: -
Sep 19, 2022
Upgrades: Outperform
Price Target: n/a
Current: $3.02
Upside: -
Jun 7, 2022
Initiates: Outperform
Price Target: n/a
Current: $322.59
Upside: -
Dec 14, 2021
Upgrades: Outperform
Price Target: n/a
Current: $39.84
Upside: -
Sep 27, 2021
Initiates: Outperform
Price Target: n/a
Current: $1.47
Upside: -
Feb 24, 2020
Initiates: Outperform
Price Target: $116
Current: $125.44
Upside: -7.53%